Arteriocyte Receives FDA Approval to Initiate Cellular Therapy Trial...

The FDA Investigational Device Exemption allows Arteriocyte and its clinical partners to initiate evaluation of autologous platelet gel as an adjunctive therapy for autologous skin grafting in patients with thermal injuries.

http://www.pmpnews.com/node/18588